Scientists are closing in on the brain’s internal circuitry for hunger, revealing a surprisingly precise “off switch” that ...

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

For these women, menopause wasn’t to be experienced quietly. With the help of their doctors and the right treatment option, ...

With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.

Denmark-based Curasight has dosed the first patient in the Phase I clinical trial of its uTREAT diagnostic platform, ...

You pour your morning coffee, reach for that familiar packet or bottle to make it taste just right, and think nothing of it.

Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment ...

There has been an explosion of newer HER2-directed therapies, including monoclonal antibodies, novel antibody-drug conjugates ...

Researchers have long believed — and the authors of a new study hypothesized — that schizophrenics have lower brain levels of the neurotransmitter serotonin, and that those lower levels are associated ...

E-cigarettes, nicotine pouches, and heated tobacco hurt blood vessels, increase heart disease risk. All nicotine products ...